US Stock MarketDetailed Quotes

Voyager Therapeutics (VYGR)

Watchlist

3.760
+0.030+0.80%

Close May 1 16:00 ET

3.750
-0.010-0.27%

Post 20:01 ET

227.17MMarket Cap-1.84P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Voyager Therapeutics (VYGR) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-765.23%-132.47M

-108.29%-30.26M

-11.01%-31.05M

-5.32%-33.26M

-164.48%-37.9M

-119.65%-15.31M

38.85%-14.53M

-32.86%-27.97M

-3,682.04%-31.58M

-52.44%58.77M

Net income from continuing operations

-84.18%-119.72M

20.47%-27.43M

-208.40%-27.89M

-229.18%-33.38M

-173.80%-31.02M

-149.12%-65M

-161.15%-34.49M

65.08%-9.04M

54.34%-10.14M

-109.13%-11.33M

Operating gains losses

-72.35%141K

93.75%62K

--0

-78.41%49K

-49.15%30K

186.52%510K

-8.57%32K

910.53%192K

183.75%227K

34.09%59K

Depreciation and amortization

-14.18%4.06M

3.76%1.05M

-17.67%932K

-23.49%1.07M

-15.22%1.01M

6.53%4.73M

-24.27%1.01M

19.79%1.13M

28.18%1.39M

11.26%1.2M

Other non cash items

----

15.52%1.22M

----

--1.06M

Change In working capital

-182.51%-28.76M

-141.57%-6.94M

68.11%-6.89M

88.18%-3.11M

-117.86%-11.81M

152.37%34.86M

120.16%16.69M

-868.03%-21.62M

-250.23%-26.36M

1,698.04%66.14M

-Change in receivables

-99.67%268K

-87.85%2.13M

90.79%-1.51M

-301.46%-415K

-99.91%70K

197.69%81.31M

121.80%17.49M

-17,024.74%-16.42M

-99.06%206K

419.23%80.03M

-Change in prepaid assets

237.69%3.62M

387.23%2.29M

382.27%3.15M

-127.15%-2.69M

209.32%868K

-3,556.58%-2.63M

12.44%470K

-424.71%-1.12M

43.44%-1.19M

-156.27%-794K

-Change in payables and accrued expense

-470.38%-1.48M

-108.08%-288K

82.31%3.14M

196.53%2.14M

-94.59%-6.48M

-103.23%-260K

-13.15%3.57M

-51.45%1.72M

-257.33%-2.22M

-429.70%-3.33M

-Change in other current assets

5.96%4.87M

7.50%1.26M

24.42%1.23M

-2.90%2.38M

--0

132.76%4.6M

127.52%1.17M

97.41%991K

401.43%2.45M

-103.20%-15K

-Change in other current liabilities

-117.68%-7.23M

-15.23%-1.87M

-15.18%-1.84M

-80.10%-1.79M

-294.16%-1.73M

-17.19%-3.32M

-121.89%-1.62M

-122.32%-1.59M

-41.74%-995K

230.45%891K

-Change in other working capital

35.76%-28.81M

-138.57%-10.46M

-112.69%-11.08M

88.90%-2.73M

57.32%-4.54M

-576.33%-44.84M

35.96%-4.38M

-441.27%-5.21M

-1,537.26%-24.61M

-156.84%-10.64M

Cash from discontinued investing activities

Operating cash flow

-765.23%-132.47M

-108.29%-30.26M

-11.01%-31.05M

-5.32%-33.26M

-164.48%-37.9M

-119.65%-15.31M

38.85%-14.53M

-32.86%-27.97M

-3,682.04%-31.58M

-52.44%58.77M

Investing cash flow

Cash flow from continuing investing activities

232.24%125.45M

274.33%47.42M

-45.79%34.89M

105.38%1.93M

142.89%41.2M

33.03%-94.86M

-201.38%-27.2M

140.65%64.35M

-45.74%-35.94M

-762.93%-96.07M

Net PPE purchase and sale

26.27%-2.6M

-303.87%-626K

19.77%-207K

-14.27%-1.11M

69.27%-658K

-8.14%-3.52M

79.47%-155K

67.01%-258K

20.08%-967K

-320.63%-2.14M

Net investment purchase and sale

240.18%128.04M

277.65%48.05M

-45.68%35.1M

108.69%3.04M

144.57%41.86M

34.00%-91.34M

-198.04%-27.05M

141.02%64.61M

-49.13%-34.98M

-726.16%-93.92M

Cash from discontinued investing activities

Investing cash flow

232.24%125.45M

274.33%47.42M

-45.79%34.89M

105.38%1.93M

142.89%41.2M

33.03%-94.86M

-201.38%-27.2M

140.65%64.35M

-45.74%-35.94M

-762.93%-96.07M

Financing cash flow

Cash flow from continuing financing activities

-99.28%816K

-76.31%136K

507.14%85K

-10.16%513K

-99.93%82K

238.88%114.02M

24.78%574K

-95.77%14K

-63.11%571K

260.49%112.86M

Net common stock issuance

--0

262.39%112.78M

--0

262.39%112.78M

Proceeds from stock option exercised by employees

-34.03%816K

-76.31%136K

507.14%85K

-10.16%513K

5.13%82K

-50.99%1.24M

24.78%574K

-95.77%14K

-63.11%571K

-57.84%78K

Cash from discontinued financing activities

Financing cash flow

-99.28%816K

-76.31%136K

507.14%85K

-10.16%513K

-99.93%82K

238.88%114.02M

24.78%574K

-95.77%14K

-63.11%571K

260.49%112.86M

Net cash flow

Beginning cash position

5.46%74.24M

-56.03%50.74M

-40.74%46.81M

-46.81%77.63M

5.46%74.24M

-29.94%70.4M

72.59%115.4M

-67.87%79M

-45.91%145.95M

-29.94%70.4M

Current changes in cash

-261.34%-6.21M

142.03%17.3M

-89.22%3.93M

53.97%-30.82M

-95.52%3.39M

112.79%3.85M

-1,264.96%-41.16M

120.33%36.4M

-179.55%-66.95M

-55.39%75.56M

End cash Position

-8.36%68.04M

-56.03%50.74M

-40.74%46.81M

-46.81%77.63M

5.46%74.24M

72.59%115.4M

-67.87%79M

-45.91%145.95M

Free cash flow

-617.24%-135.06M

-110.36%-30.89M

-10.73%-31.26M

-5.59%-34.37M

-168.08%-38.55M

-125.22%-18.83M

40.10%-14.68M

-29.28%-28.23M

-1,491.54%-32.55M

-53.98%56.63M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-765.23%-132.47M	-108.29%-30.26M	-11.01%-31.05M	-5.32%-33.26M	-164.48%-37.9M	-119.65%-15.31M	38.85%-14.53M	-32.86%-27.97M	-3,682.04%-31.58M	-52.44%58.77M
Net income from continuing operations	-84.18%-119.72M	20.47%-27.43M	-208.40%-27.89M	-229.18%-33.38M	-173.80%-31.02M	-149.12%-65M	-161.15%-34.49M	65.08%-9.04M	54.34%-10.14M	-109.13%-11.33M
Operating gains losses	-72.35%141K	93.75%62K	--0	-78.41%49K	-49.15%30K	186.52%510K	-8.57%32K	910.53%192K	183.75%227K	34.09%59K
Depreciation and amortization	-14.18%4.06M	3.76%1.05M	-17.67%932K	-23.49%1.07M	-15.22%1.01M	6.53%4.73M	-24.27%1.01M	19.79%1.13M	28.18%1.39M	11.26%1.2M
Other non cash items	----	----	----	----	15.52%1.22M	----	----	----	----	--1.06M
Change In working capital	-182.51%-28.76M	-141.57%-6.94M	68.11%-6.89M	88.18%-3.11M	-117.86%-11.81M	152.37%34.86M	120.16%16.69M	-868.03%-21.62M	-250.23%-26.36M	1,698.04%66.14M
-Change in receivables	-99.67%268K	-87.85%2.13M	90.79%-1.51M	-301.46%-415K	-99.91%70K	197.69%81.31M	121.80%17.49M	-17,024.74%-16.42M	-99.06%206K	419.23%80.03M
-Change in prepaid assets	237.69%3.62M	387.23%2.29M	382.27%3.15M	-127.15%-2.69M	209.32%868K	-3,556.58%-2.63M	12.44%470K	-424.71%-1.12M	43.44%-1.19M	-156.27%-794K
-Change in payables and accrued expense	-470.38%-1.48M	-108.08%-288K	82.31%3.14M	196.53%2.14M	-94.59%-6.48M	-103.23%-260K	-13.15%3.57M	-51.45%1.72M	-257.33%-2.22M	-429.70%-3.33M
-Change in other current assets	5.96%4.87M	7.50%1.26M	24.42%1.23M	-2.90%2.38M	--0	132.76%4.6M	127.52%1.17M	97.41%991K	401.43%2.45M	-103.20%-15K
-Change in other current liabilities	-117.68%-7.23M	-15.23%-1.87M	-15.18%-1.84M	-80.10%-1.79M	-294.16%-1.73M	-17.19%-3.32M	-121.89%-1.62M	-122.32%-1.59M	-41.74%-995K	230.45%891K
-Change in other working capital	35.76%-28.81M	-138.57%-10.46M	-112.69%-11.08M	88.90%-2.73M	57.32%-4.54M	-576.33%-44.84M	35.96%-4.38M	-441.27%-5.21M	-1,537.26%-24.61M	-156.84%-10.64M
Cash from discontinued investing activities
Operating cash flow	-765.23%-132.47M	-108.29%-30.26M	-11.01%-31.05M	-5.32%-33.26M	-164.48%-37.9M	-119.65%-15.31M	38.85%-14.53M	-32.86%-27.97M	-3,682.04%-31.58M	-52.44%58.77M
Investing cash flow
Cash flow from continuing investing activities	232.24%125.45M	274.33%47.42M	-45.79%34.89M	105.38%1.93M	142.89%41.2M	33.03%-94.86M	-201.38%-27.2M	140.65%64.35M	-45.74%-35.94M	-762.93%-96.07M
Net PPE purchase and sale	26.27%-2.6M	-303.87%-626K	19.77%-207K	-14.27%-1.11M	69.27%-658K	-8.14%-3.52M	79.47%-155K	67.01%-258K	20.08%-967K	-320.63%-2.14M
Net investment purchase and sale	240.18%128.04M	277.65%48.05M	-45.68%35.1M	108.69%3.04M	144.57%41.86M	34.00%-91.34M	-198.04%-27.05M	141.02%64.61M	-49.13%-34.98M	-726.16%-93.92M
Cash from discontinued investing activities
Investing cash flow	232.24%125.45M	274.33%47.42M	-45.79%34.89M	105.38%1.93M	142.89%41.2M	33.03%-94.86M	-201.38%-27.2M	140.65%64.35M	-45.74%-35.94M	-762.93%-96.07M
Financing cash flow
Cash flow from continuing financing activities	-99.28%816K	-76.31%136K	507.14%85K	-10.16%513K	-99.93%82K	238.88%114.02M	24.78%574K	-95.77%14K	-63.11%571K	260.49%112.86M
Net common stock issuance	--0	--0	--0	--0	--0	262.39%112.78M	--0	--0	--0	262.39%112.78M
Proceeds from stock option exercised by employees	-34.03%816K	-76.31%136K	507.14%85K	-10.16%513K	5.13%82K	-50.99%1.24M	24.78%574K	-95.77%14K	-63.11%571K	-57.84%78K
Cash from discontinued financing activities
Financing cash flow	-99.28%816K	-76.31%136K	507.14%85K	-10.16%513K	-99.93%82K	238.88%114.02M	24.78%574K	-95.77%14K	-63.11%571K	260.49%112.86M
Net cash flow
Beginning cash position	5.46%74.24M	-56.03%50.74M	-40.74%46.81M	-46.81%77.63M	5.46%74.24M	-29.94%70.4M	72.59%115.4M	-67.87%79M	-45.91%145.95M	-29.94%70.4M
Current changes in cash	-261.34%-6.21M	142.03%17.3M	-89.22%3.93M	53.97%-30.82M	-95.52%3.39M	112.79%3.85M	-1,264.96%-41.16M	120.33%36.4M	-179.55%-66.95M	-55.39%75.56M
End cash Position	-8.36%68.04M	-8.36%68.04M	-56.03%50.74M	-40.74%46.81M	-46.81%77.63M	5.46%74.24M	5.46%74.24M	72.59%115.4M	-67.87%79M	-45.91%145.95M
Free cash flow	-617.24%-135.06M	-110.36%-30.89M	-10.73%-31.26M	-5.59%-34.37M	-168.08%-38.55M	-125.22%-18.83M	40.10%-14.68M	-29.28%-28.23M	-1,491.54%-32.55M	-53.98%56.63M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm